article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes. Discussions will focus on the nuanced packaging and delivery requirements for MABs, emphasizing the commitment to safety standards while ensuring the drugs’ effectiveness.

article thumbnail

How AI is Shaping Drug Discovery at AION Labs

Healthcare IT Today

In our interview, Gil emphasizes the critical role of AI in expediting the discovery of new drugs, citing the lengthy and costly nature of traditional drug development processes. However, with AI-driven approaches, Aion Labs is paving the way for a paradigm shift in drug discovery. Tell us what you think.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Accenture Invests in QuantHealth to Accelerate Use of AI-Powered Clinical Trial Simulations to Drive Cost-Effective Drug Development

Healthcare IT Today

Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients. Petra Jantzer, Ph.D.,

article thumbnail

How Technology Can Help Overcome Barriers to Getting Effective Therapies into Patients with Ultra Rare Disorders

Healthcare IT Today

Already, this real-world, distributed time of diagnosis approach, has been used to cut down more than four years of estimated drug development timeline in the instance of PRAX-222, a new therapy for SCN2A, a rare genetic disorder of pediatric epilepsy.

article thumbnail

Protai Adds $12 Million to Seed Round – Bringing the Total to $20 Million – to Build an Oncology Drug Discovery Pipeline

Healthcare IT Today

With the additional funding, Protai will expand its activities to include an oncology drug discovery pipeline, initially focusing on targets with a clearly-defined novel patient population biomarker, derived from its AI proteomics platform. In addition, Protai is supported by leading oncology experts, including Prof.

article thumbnail

PhaseV Raises $15 Million to Push the Boundaries of ML for Clinical Trial Optimization

Healthcare IT Today

This ML-driven adaptive process can significantly accelerate the clinical drug development process and increase certainty along the way, resulting in more efficient, targeted, and ultimately more successful clinical trials. bringing new needed treatments to patients.”

article thumbnail

Pharma – 2023 Health IT Predictions

Healthcare IT Today

We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes. The new year will bear witness to great innovation in biotech in the precision oncology space. The big question that remains is who will have access to these drugs and when?